Abstract
Endometriya giperplaziyasi – ayollar salomatligiga sezilarli tahdid soluvchi patologik holat bo‘lib, u endometrial shilliq qavatining hujayralar proliferatsiyasining ortishi bilan tavsiflanadi. Ushbu maqola endometriya giperplaziyasining patofiziologiyasi, xavf omillari va zamonaviy skrining usullarini tahlil qiladi. Shuningdek, giperplaziya va endometrial karsinoma rivojlanishining oldini olish, diagnostika va monitoring strategiyalarini ishlab chiqish bo‘yicha zamonaviy yondashuvlar ko‘rib chiqiladi.
References
1. Kurman, R. J., Carcangiu, M. L., Herrington, C. S., & Young, R. H. (2014). WHO Classification of Tumours of Female Reproductive Organs (4th ed.). Lyon: IARC.
2. Lax, S. F. (2010). Endometrial hyperplasia and endometrial carcinoma: Pathogenesis and diagnostic considerations. Histopathology, 56(1), 12–24.
3. Trimble, C. L., et al. (2006). Endometrial hyperplasia and risk of progression to endometrial cancer. Obstetrics & Gynecology, 108(3), 523–530.
4. Amant, F., et al. (2005). Endometrial cancer in postmenopausal women: Risk factors and clinical implications. The Lancet Oncology, 6(12), 1019–1027.
5. Lethaby, A., et al. (2013). Endometrial surveillance for postmenopausal bleeding: A systematic review. Cochrane Database of Systematic Reviews, 2013(1), CD001416.
6. Giannella, L., et al. (2016). Endometrial hyperplasia: Screening and management strategies. Menopause, 23(6), 650–657.
7. Bansal, N., et al. (2009). Endometrial hyperplasia: Diagnosis, management, and clinical outcomes. Obstetrics & Gynecology, 113(3), 684–692.